IGC
Igc Pharma, Inc.
Clinical-stage biotechnology company focused on developing AI-driven treatments for Alzheimer's disease and related neurodegenerative disorders
CUSIP: 45408X100HealthcareUS1 holder
Igc Pharma, Inc.
Clinical-stage biotechnology company focused on developing AI-driven treatments for Alzheimer's disease and related neurodegenerative disorders
No insider transactions reported in the last 5 years. Look across all recorded history →